Estudio de Everself y Harvard: ESG ayuda a seguir perdiendo peso tras suspender los GLP-1
Harvard Assistant Professor, Chair of American Society for Gastrointestinal Endoscopy's Advanced Endoscopy Committee, Everself Co-founder
Encuentre artículos detallados y actualizaciones sobre procedimientos de pérdida de peso y medicamentos GLP-1, accesibles y fáciles de entender.
Harvard Assistant Professor, Chair of American Society for Gastrointestinal Endoscopy's Advanced Endoscopy Committee, Everself Co-founder
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Harvard Assistant Professor, Chair of American Society for Gastrointestinal Endoscopy's Advanced Endoscopy Committee, Everself Co-founder
Bariendo es ahora Everself. Más información